Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

Hepatology

Volumn 28, Issue 2, 1998, Pages 585-589

  Markowitz, Jay S ^a,d   Martin, Paul ^a   Conrad, Andrew J ^c   Markmann, James F ^a   Seu, Philip ^a   Yersiz, Hasan ^a   Goss, John A ^a   Schmidt, Peter ^b   Pakrasi, Anita ^a   Artinian, Lucy ^a   Murray, Natalie G B ^b   Imagawa, David K ^b   Holt, Curtis ^a   Goldstein, Leonard I ^a   Stribling, Risë ^a   Busuttil, Ronald W ^a  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c National Genetics Institute   (United States)

^d University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HEPATITIS B ANTIBODY; LAMIVUDINE; TACROLIMUS;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEPATITIS B; HUMAN; INFECTION PREVENTION; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; LAMIVUDINE; LIVER; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RECURRENCE; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

EID: 17344364991     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280241     Document Type: Article

References (19)

1. Demetris AJ, Todo S, Van Thiel DH, Fung JJ, Iwaki Y, Sysyn G, Ming W, et al. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am J Pathol 1990;137:667-676.
2. O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, Portmann B, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 1992;14:104-111.
3. Eason JD, Freeman RB, Jr, Rohrer RJ, Lewis WD, Jenkins R, Dienstag J, Cosimi AB. Should liver transplantation be performed for patients with hepatitis B? Transplantation 1994;57:1588-1593.
4. Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, Brechot C, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991;337:813-815.
5. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847.
6. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. HEPATOLOGY 1998;27:213-222.
7. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. HEPATOLOGY 1998;27:254-263.
8. Lemmens HP, Langrehr JM, Blumhardt G, Lohmann R, Knopp M, Verschl J, Schattenfroh N, et al. Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis. Transplant Proc 1994;26:3622-3623.
9. Langrehr JM, Lemmens HP, Keck H, Lohmann R, Knopp M, Neumann U, Muller AR, et al. Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. Transplant Proc 1995;27:1215-1216.
10. Grazi GL, Mazziotti A, Sama C, Jovine E, Stefanini F, Paladini R, Rossi R, et al. Liver transplantation in HBsAg-positive HBV-DNA-negative cirrhotics: immunoprophylaxis and long-term outcome. Liver Transplantation and Surgery 1996;2:418-425.
11. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. HEPATOLOGY 1996;24:1327-1333.
12. Jurim O, Martin P, Shaked A, Goldstein L, Millis JM, Calquhoun SD, Gitnick G, et al. Liver transplantation for chronic hepatitis B in Asians. Transplantation 1994;57:1393-1395.
13. McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, Caldwell SH, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996;61:1358-1364.
14. Benhamou Y, Katlama C, Lunel F, Coutellier A, Dohin E, Hamm N, Tubiana R, et al. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med 1996;125:705-12.
15. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995;333:1657-1661.
16. Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, McMaster P, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996;348:1212-1215.
17. Markowitz J, Pakrasi A, Hollis P, Martin P, Goldstein L, Busuttil R. Efficacy of lamivudine for prophylaxis and treatment of hepatitis B in liver transplant patients [Abstract]. HEPATOLOGY 1996;24:182A.
18. Perrillo R, Rakela J, Martin P, Levy G, Schiff E, Wright T, Dienstag J, et al. Lamivudine for hepatitis B after liver transplantation (OLT) [Abstract]. HEPATOLOGY 1996;24:182A.
19. Tisdale M, Kemp SD, Parry NR, Larder BA. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc Natl Acad Sci U S A 1993;90:5653-5656.